Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers.
As a global leader of innovative and comprehensive laboratory services, we help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities.
Our more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world.
Learn more about Labcorp (NYSE: LH) at www.labcorp.com.
Established in 1949, Dr Lal PathLabs today is the largest and most respected diagnostic service provider in the country. It has a proven track record of over six decades for strict adherence to international standards and benchmarks. Dr Lal PathLabs offers widest test menu and has a pan India presence in all important cities and towns of India, in the form of state-of-the-art laboratories and patient service centres.
The company has more than 190 Labs and over 2000 centers across India and international operations in Nepal and Bangladesh.
It serves over 13 million customers every year through its widest test menu and panels in the disciplines of Molecular Diagnostics, Biophysics, Flow Cytometry, Immunophenotying, Cytogenetics, Endocrinology, Genetics, Nutrition and Metabolism, Oncology, Toxicology, Immunohistochemistry, Infectious diseases, Biochemistry, Haematology, Histopathology and Cytology.
Dr Lal PathLabs has internationally accepted external and internal quality assurance programs in place. The Company is India's highest accredited laboratory, with accreditation from College of American Pathologists (CAP), National Accreditation Board for Testing and Calibration Laboratories (NABL), Ministry of Science and Technology, Govt. of India, and ISO 9001:2000 certification.